Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sex-specific disease outcomes of HIV-positive and HIV-negative drug users admitted to an opioid substitution therapy program in Spain, a cohort study

  • Muga, Roberto|||0000-0001-6301-431X
  • Rivas, Inmaculada|||0000-0003-2633-5530
  • Faure, Eva|||0000-0002-5056-0888
  • Fuster, Daniel|||0000-0003-1262-5860
  • Zuluaga Cruz, Andrea Paola|||0000-0002-3003-4856
  • Rubio, Manuela
  • Muñoz, Trinidad
  • Torrens, Marta
  • Tor Aguilera, Jordi|||0000-0002-5355-9110
  • Sanvisens, Arantza|||0000-0001-6269-5491
Opioid substitution therapy has improved the survival of heroin users with and without HIV infection. We aimed to analyze sex differences in mortality rates and predictors of death among those admitted to a methadone treatment program (MTP). Longitudinal study of patients enrolled in a MTP from 1992 to 2010. Socio-demographic and drug use characteristics, and markers of viral infections were assessed at entry. Vital status was ascertained by clinical charts and the mortality register. Four calendar periods were defined according to the introduction of preventive and treatment interventions in Spain. Predictors of death were analyzed by Cox regression models. 1,678 patients (82.8% men) were included; age at first heroin use was 18.6 years (IQR: 16-23 years), and age at first entry into a MTP was 30.7 years (IQR: 26-36 years). A total of 441 (26.3%) deaths occurred during 15,124 person-years (p-y) of follow-up (median: 9.2 years, IQR: 4-13 years). HIV infection was the main predictor of death in men (HR = 3.5, 95% CI: 2.1-5.7) and women (HR = 3.2, 95% CI: 1.2-8.7) and main cause of death was HIV/AIDS. Overall mortality rate was 2.9 per 100 p-y (95% CI: 2.7-3.2 per 100 p-y) and death rates decreased over time: 7.4 per 100 p-y (95% CI: 6.3-8.8 per 100 p-y) for the 1992-1996 period to 1.9 per 100 p-y (95% CI: 1.6-2.4 per 100 p-y) for the 2007-2010 period. In women, a slightly increase in mortality was observed in recent periods specifically among HIV-positive women (3.7 per 100 p-y in period 2002-2006 and 4.5 per 100 p-y in 2007-2010). Significant reductions in mortality of patients in MTP are observed after nineteen years of observation. However, HIV infection shows a great impact on survival, particularly among HIV-infected women. The online version of this article (doi:10.1186/1471-2334-14-504) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients

  • Falcon-Neyra, Lola
  • Palladino, Claudia
  • Navarro, Maria Luisa
  • Soler Palacín, Pere|||0000-0002-0346-5570
  • González-Tomé, María Isabel
  • De Ory, Santiago J.
  • Frick, Marie Antoinette|||0000-0002-2553-5090
  • Fortuny Guasch, Claudia
  • Noguera-Julian, Antoni|||0000-0001-7485-0583
  • Bermúdez Moreno, Elena
  • Santos, Juan Luis
  • Olbrich, Peter
  • López Cortés, Luis Fernando|||0000-0002-3804-3458
  • Briz, Verónica|||0000-0003-2297-5098
  • Neth, Olaf|||0000-0001-5018-0466
To assess the safety and efficacy of rilpivirine in combination with emtricitabine and tenofovir (RPV/FTC/TDF) as a once-daily single-tablet regimen (STR) in HIV-1-infected children and adolescents we performed a multicenter case series study of HIV-1-infected patients. Inclusion criteria were initiation of therapy with RPV/FTC/TDF before the age of 18. Patients were divided into undetectable viral load (uVL) group, HIV-1 RNA < 20 copies/mL on stable combined antiretroviral therapy (cART), and detectable viral load (dVL) group, HIV-1 RNA ≥ 20 copies/mL at RPV/FTC/TDF initiation. Patients were monitored from the date of RPV/FTC/TDF initiation until June 30, 2015, RPV/FTC/TDF discontinuation or failure to follow-up. Seventeen patients (8 in uVL and 9 in dVL group) with age between 11.6 and 17.6 were included. Reasons for switching were toxicity (n = 4) and simplification (n = 4) in uVL; viral failure (n = 8) and cART initiation (n = 1) in the dVL group. After a median follow-up of 90 (uVL) and 40 weeks (dVL), 7/8 (86%) patients maintained and 8/9 (89%) achieved and maintained HIV-1 suppression. Median CD4 count increased from 542 to 780/μL (uVL, P = 0.069) and 480 to 830/μL (dVL, P = 0.051). Five patients (2 in uVL and 3 in dVL) improved their immunological status from moderate to no immunosuppression. Serum lipid profiles improved in both groups; cholesterol dropped significantly in the dVL group (P = 0.008). Grade 1 laboratory adverse events (AEs) were observed in 3 patients. No clinical AEs occurred. Adherence was complete in 9 patients (5 in uVL and 4 in dVL); 1 adolescent interrupted treatment. Once-daily STR with RPV/FTC/TDF may be a safe and effective choice in selected HIV-1-infected adolescents and children.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Low CD4/CD8 ratio is associated with increased morbidity and mortality in late and non-late presenters, results from a multicentre cohort study, 2004-2018

  • Domínguez-Domínguez, Lourdes|||0000-0001-6018-9026
  • Rava, Marta|||0000-0003-2260-9370
  • Bisbal, Otilia|||0000-0003-3746-3378
  • Lopez-Cortés, Luis
  • Portilla, Joaquín|||0000-0002-3676-9511
  • Podzamczer, Daniel|||0000-0001-7090-3561
  • Olalla, Julián
  • Fuster, Daniel|||0000-0003-1262-5860
  • Rubio, Rafael
  • Jarrín, Inmaculada
  • Iribarren, José Antonio
  • Moreno, Santiago|||0000-0002-2843-1094
To study whether the association between the CD4/CD8 ratio variation over time and the development of clinical outcomes vary in late presenters (CD4 count < 350/µL or AIDS event at enrolment) or advanced presenters (CD4 count < 200/µL or AIDS event at enrolment). We included ART-naïve adults from the Cohort of the Spanish HIV/AIDS Research Network (CoRIS) enrolled between January 2004 up to November 2018 and with at least 6 months of follow-up. We used extended Cox proportional hazard models to estimate the hazard ratios (HRs) for the association between CD4/CD8 ratio over time and a composite endpoint of the occurrence of the first AIDS event, first serious non-AIDS event or overall mortality occurring from 6 months after enrolment. HRs in non-late, late and advanced presenters were obtained by including an interaction term between late presentation status and CD4/CD8 ratio over time. Of 10,018 participants, 55.6% were late presenters and 26.5% were advanced presenters. Compared with CD4/CD8 ratio > 0.4, CD4/CD8 ratio ≤ 0.4 over time was associated with an increased risk of experiencing the composite endpoint in non-late (HR 1.90; 95%CI 1.48, 2.43), late (HR 1.94; 1.46, 2.57) and advanced presenters (HR 1.72; 1.26, 2.34). Similarly, CD4/CD8 ratio ≤ 0.4 over time was associated with a higher risk of developing an AIDS event (HR 3.31; 2.23, 4.93 in non-late; HR 2.75; 1.78, 4.27 in late and HR 2.25; 1.34, 3.76 in advanced presenters) or serious non-AIDS event (HR 1.39; 0.96, 2.02 in non-late, HR 1.62; 1.10, 2.40 in late and HR 1.49; 0.97, 2.29 in advanced presenters) as well as with a higher risk of overall mortality (HR 1.49; 0.92, 2.41 in non-late, HR 1.80; 1.04, 3.11 in late and HR 1.61; 0.92, 2.83 in advanced presenters) compared to CD4/CD8 > 0.4, regardless of the late presentation status. A low CD4/CD8 measured over time is associated with increased risk of morbidity and mortality in people living with HIV independently of their late presentation status. These data support the prognostic role of CD4/CD8 over time and can help defining a subgroup of patients who need closer monitoring to avoid comorbidities. The online version contains supplementary material available at 10.1186/s12879-022-07352-z.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors

  • Alejos, Belén|||0000-0001-9571-6471
  • Suárez-García, Inés|||0000-0002-7016-716X
  • Bisbal, Otilia|||0000-0003-3746-3378
  • Iribarren, José Antonio
  • Asensi, Víctor
  • Górgolas, Miguel
  • Muga, Roberto|||0000-0001-6301-431X
  • Moreno, Santiago|||0000-0002-2843-1094
  • Jarrín, Inma|||0000-0002-7485-2252
Background We aimed to describe the most frequently prescribed initial antiretroviral therapy (ART) regimens in recent years in HIV-positive persons in the Cohort of the Spanish HIV/AIDS Research Network (CoRIS) and to investigate factors associated with the choice of each regimen. Methods We analyzed initial ART regimens prescribed in adults participating in CoRIS from 2014 to 2017. Only regimens prescribed in >5% of patients were considered. We used multivariable multinomial regression to estimate Relative Risk Ratios (RRRs) for the association between sociodemographic and clinical characteristics and the choice of the initial regimen. Results Among 2874 participants, abacavir(ABC)/lamivudine(3TC)/dolutegavir(DTG) was the most frequently prescribed regimen (32.1%), followed by tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC)/elvitegravir(EVG)/cobicistat(COBI) (14.9%), TDF/FTC/rilpivirine (RPV) (14.0%), tenofovir alafenamide (TAF)/FTC/EVG/COBI (13.7%), TDF/FTC+DTG (10.0%), TDF/FTC+darunavir/ritonavir or darunavir/cobicistat (bDRV) (9.8%) and TDF/FTC+raltegravir (RAL) (5.6%). Compared with ABC/3TC/DTG, starting TDF/FTC/RPV was less likely in patients with CD4100.000 copies/mL. TDF/FTC+DTG was more frequent in those with CD4100.000 copies/mL. TDF/FTC+RAL and TDF/FTC+bDRV were also more frequent among patients with CD4 Conclusions The choice of initial ART regimens is consistent with Spanish guidelines' recommendations, but is also clearly influenced by physician's perception based on patient's clinical and sociodemographic variables and by the prescribing hospital location.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

  • Suárez-García, Inés|||0000-0002-7016-716X
  • Alejos, Belén
  • Pérez Elías, Mª Jesus|||0000-0001-5700-5257
  • Iribarren, José Antonio
  • Hernando, Asunción|||0000-0002-1901-1119
  • Ramírez, Margarita
  • Tasias, María
  • Pascual, Mario
  • Jarrín, Inma|||0000-0002-7485-2252
  • Hernando, Victoria
  • Navarro, Maria Luisa
  • González, Maria Isabel
  • Moreno Prieto, Cristina|||0000-0002-3378-3158
  • Iniesta, Carlos|||0000-0002-0928-2679
  • Sousa, Luis Miguel García
  • Perez, Nieves Sanz
  • Rava, Marta|||0000-0003-2260-9370
  • Muñoz Fernández, María Ángeles
  • Consuegra Fernández, Irene
  • Merino, Esperanza
  • García, Gema
  • Portilla, Irene
  • Agea, Iván
  • Portilla, Joaquín|||0000-0002-3676-9511
  • Sánchez Payá, José
  • Rodríguez, Juan Carlos
  • Gimeno, Lina
  • Giner, Livia|||0000-0002-1885-3736
  • Díez, Marcos
  • Carreres, Melissa
  • Reus, Sergio|||0000-0002-3320-9754
  • Boix, Vicente|||0000-0002-7015-3948
  • Torrús-Tendero, Diego
  • Lirola, Ana López
  • García, Dácil
  • Díaz-Flores, Felicitas
  • Gómez, Juan Luis
  • del Mar Alonso, María
  • Pelazas, Ricardo
  • Hernández, Jehovana
  • Alemán, María Remedios
  • Hernández, María Inmaculada
  • Asensi, Victor|||0000-0003-4211-456X
  • Valle, Eulalia
  • Carmenado, Maria Eugenia Rivas
  • Secades, Tomás Suárez Zarracina
  • Is, Laura Pérez
  • Rubio, Rafael
  • Pulido, Federico|||0000-0002-7414-8812
  • Bisbal, Otilia|||0000-0003-3746-3378
  • Domínguez-Domínguez, Lourdes|||0000-0001-6018-9026
  • Crestelo, David Rial
  • Bermejo, Laura
  • Santacreu, Mireia
  • Arrizabalaga, Julio
  • Aramburu, Maria José
  • Camino, Xabier
  • Rodríguez-Arrondo, Francesc
  • Von Wichmann, Miguel Ángel
  • Tomé, Lidia Pascual
  • Goenaga, Miguel Ángel
  • Bustinduy, Maria Jesús
  • Azkune, Harkaitz
  • Ibarguren, Maialen
  • Lizardi, Aitzibir
  • Kortajarena, Xabier
  • Oyaga, Maria Pilar Carmona
  • Igartua, Maitane Umerez
  • Gutiérrez, Félix|||0000-0002-9485-6867
  • Masiá, Mar|||0000-0001-9878-2458
  • Padilla Urrea, Sergio|||0000-0002-8420-7310
  • Robledano, Catalina
  • Colomé, Joan Gregori
  • Adsuar, Araceli
  • Pascual, Rafael
  • Fernández, Marta
  • García, José Alberto
  • Barber, Xavier|||0000-0003-3079-5855
  • Re, Vanessa Agullo
  • Abellán, Javier Garcia
  • Pérez, Reyes Pascual
  • Roca, Maria
  • Muga, Roberto|||0000-0001-6301-431X
  • Sanvisens, Arantza|||0000-0001-6269-5491
  • Fuster, Daniel|||0000-0003-1262-5860
  • Berenguer, Juan|||0000-0001-8541-8200
  • López Bernaldo de Quirós, Juan Carlos|||0000-0002-8989-9758
  • Gutiérrez, Isabel
  • Padilla Ortega, Belén
  • Gijon, Paloma|||0000-0002-5011-1927
  • Aldámiz-Echevarría Lois, Maria Teresa|||0000-0002-4374-6940
  • Tejerina, Francisco|||0000-0002-4136-3575
  • Parras, Francisco José
  • Balsalobre, Pascual
  • Diez, Cristina
  • Pérez Latorre, Leire|||0000-0001-9919-3778
  • Fanciulli, Chiara|||0000-0003-2175-9027
  • Vidal, Francesc|||0000-0002-6692-6186
  • Peraire, Joaquim|||0000-0001-7808-5479
  • Viladés, Consuelo|||0000-0002-2991-9593
  • Veloso, Sergio
  • Vargas Laguna, Montserrat|||0000-0001-7650-0587
  • Olona, Montserrat|||0000-0001-5303-9361
  • Rull, Anna|||0000-0002-8907-7754
  • Rodríguez-Gallego, Esther|||0000-0002-6363-2510
  • Alba, Verónica|||0000-0002-5925-9573
  • Castellanos, Alfonso Javier
  • López-Dupla, Miguel
  • Moreno Alonso, Marta
  • Aldeguer, José López
  • Juliá, Marino Blanes
  • Pitarch, Maria Tasias
  • Hernández, Iván Castro
  • Muñoz, Eva Calabuig
  • Tovar, Sandra Cuéllar
  • Lletí, Miguel Salavert
  • Navarro, Juan Fernández
  • González García, Juan|||0000-0002-3652-002X
  • Arnalich Fernandez, Francisco|||0000-0003-2943-0373
  • Arribas, José Ramón
  • Bernardino, José Ignacio|||0000-0003-3501-8529
  • Busca, Carmen
  • Cano, Joanna
  • Cardiñanos, Julen
  • Castro, Juan Miguel
  • Delgado Hierro, Ana
  • Escosa García, Luis|||0000-0003-0730-4026
  • Herranz Pinto, Pedro|||0000-0002-9840-6628
  • Hontañón Antoñana, Víctor|||0000-0003-3070-2647
  • García Bujalance, Silvia
  • López-Hortelano, Milagros García
  • González Baeza, Alicia
  • Miguel, Rosa de
  • Martín Carbonero, Luz|||0000-0001-8102-4079
  • Mayoral, Mario
  • Mellado Peña, María José|||0000-0003-2251-9666
  • Micán-Rivera, R.|||0000-0002-6626-4266
  • Montejano Sanchez, Rocio|||0000-0002-3446-0545
  • Montes, María Luisa|||0000-0003-1748-813X
  • Moreno, Victoria
  • Pérez Valero, Ignacio|||0000-0002-3488-7135
  • Cebrián, Guadalupe Rúa
  • Rodés, Berta
  • Sainz, Talia|||0000-0002-5301-0945
  • Sendagorta, Elena
  • Valencia, Eulalia|||0000-0001-6902-0120
  • Blanco, José Ramón|||0000-0002-4268-0150
  • Oteo, José A.|||0000-0001-7080-6542
  • Ibarra, Valvanera
  • Metola, Luis
  • Sanz, Mercedes
  • Pérez-Martínez, Laura|||0000-0002-1384-024X
  • Arazo, Piedad
  • Sampériz, Gloria|||0000-0003-0693-2266
  • Dalmau, David|||0000-0003-1936-478X
  • Jaén, Ángels
  • Sanmartí Vilamala, Montserrat|||0000-0002-0432-7073
  • Cairó, Mireia|||0000-0003-2386-2765
  • Martinez-Lacasa, Javier
  • Velli, Pablo
  • Font, Roser
  • Martinez, Marina
  • Aiello, Tommaso Francesco|||0000-0003-4441-6318
  • Marcotegui, Maria Riveiro
  • Repáraz, Jesús
  • Gracia Ruiz de Alda, María
  • De León Cano, María Teresa
  • Pierola Ruiz de Galarreta, Beatriz
  • Amengual Guedan, Maria Jose|||0000-0002-5385-3061
  • Navarro Rubio, Gemma|||0000-0002-7195-9046
  • Garcia, Manel Cervantes
  • Calzado, Sonia|||0000-0002-2975-6448
  • Navarro Vilasaro, Marta|||0000-0002-3784-4405
  • de los Santos Gil, Ignacio|||0000-0001-7073-5211
  • Sanz Sanz, Jesús
  • Salas Aparicio, Ana
  • Sarriá Cepeda, Cristina
  • García-Fraile Fraile, Lucio|||0000-0002-2512-6107
  • Martín Gayo, Enrique|||0000-0002-2619-6086
  • Moreno, Santiago|||0000-0002-2843-1094
  • Casado Osorio, José Luis
  • Dronda, Fernando|||0000-0002-0443-5816
  • Moreno Zamora, Ana
  • Gutiérrez, Carolina
  • Madrid, Nadia
  • del Campo, Santos|||0000-0003-2234-5432
  • Serrano-Villar, Sergio|||0000-0002-5447-3554
  • Vivancos-Gallego, María J.|||0000-0002-9373-6011
  • Martínez Sanz, Javier|||0000-0003-2020-3908
  • Anxa Urroz, Usua
  • Velasco, Tamara
  • Bernal, Enrique|||0000-0002-4041-0579
  • Cano Sánchez, Alfredo
  • Alcaraz García, Antonia
  • Bravo Urbieta, Joaquín|||0000-0003-2079-0305
  • Muñoz Perez, Ángeles
  • Alcaraz, Maria Jose
  • Villalba, Maria del Carmen
  • García, Federico
  • Quero, José Hernández
  • Muñoz Medina, Leopoldo|||0000-0001-8995-8271
  • Álvarez, Marta
  • Chueca, Natalia|||0000-0002-3420-3290
  • Vinuesa, David|||0000-0002-5663-8447
  • Martinez-Montes, Clara
  • Guerrero Beltrán, Carlos
  • de Salazar, Adolfo|||0000-0002-4318-858X
  • Fuentes López, Ana
  • Del Romero Guerrero, Jorge|||0000-0001-8922-5182
  • Raposo Utrilla, Montserrat
  • Rodríguez, Carmen
  • Puerta, Teresa
  • Carrió, Juan Carlos
  • Vera, Mar|||0000-0002-3841-7747
  • Ballesteros, Juan
  • Ayerdi, Oskar|||0000-0002-9441-8031
  • Antela, Antonio
  • Losada, Elena
  • Riera, Melchor
  • Peñaranda, María|||0000-0001-6290-3457
  • Ribas, Maria Àngels
  • Campins, Antoni A.
  • Vidal Lampurdanés, Carmen|||0000-0001-5843-8038
  • Fanjul, Francisco
  • Murillas, Javier|||0000-0003-2169-7110
  • Homar, Francisco|||0000-0003-0116-3277
  • Vilchez, Helem H.
  • Martin, Maria Luisa
  • Payeras, Antoni
  • Santos, Jesús
  • Gómez Ayerbe, Cristina
  • Viciana, Isabel
  • Palacios, Rosario
  • López, Carmen Pérez
  • González Domenec, Carmen María
  • Viciana, Pompeyo|||0000-0001-5606-0166
  • Espinosa, Nuria|||0000-0003-2249-2352
  • López Cortés, Luis Fernando|||0000-0002-3804-3458
  • Podzamczer, Daniel|||0000-0001-7090-3561
  • Imaz, Arkaitz|||0000-0001-8411-1952
  • Tiraboschi, Juan Manuel|||0000-0002-0073-873X
  • Silva, Ana
  • Saumoy, Maria|||0000-0002-0047-1991
  • Prieto, Paula
  • Ribera, Esteban|||0000-0002-3752-8808
  • Curran, Adrian|||0000-0002-1263-0814
  • Olalla Sierra, Julián
  • Pérez Stachowski, Javier|||0000-0002-5189-1953
  • del Arco Jiménez, Alfonso|||0000-0002-5432-4591
  • De La Torre, Javier
  • Prada, José Luis
  • García de Lomas Guerrero, José María|||0000-0001-8160-8488
  • Martínez, Onofre Juan
  • Vera, Francisco Jesús
  • Martínez, Lorena
  • García, Josefina
  • Alcaraz, Begoña
  • Jimeno, Amaya
  • Castro Iglesias, Angeles|||0000-0002-8418-9749
  • Pernas Souto, Berta|||0000-0002-2061-3096
  • Mena de Cea, Álvaro
  • Muñoz, Josefa
  • Zuriñe Zubero, Miren
  • Baraia-Etxaburu, Josu Mirena
  • Ugarte, Sofia Ibarra
  • Ferrero Beneitez, Oscar Luis
  • López de Munain, Josefina
  • Cámara López, Maria Mar
  • De La Peña, Mireia
  • López, Miriam
  • López Azkarreta, Iñigo
  • Galera, Carlos
  • Albendin, Helena
  • Pérez, Aurora
  • Iborra, Asunción
  • Moreno, Antonio
  • Merlos, Maria Angustias
  • Vidal, Asunción
  • Meca, Marisa
  • Amador, Concha|||0000-0003-0843-8624
  • Pasquau, Francisco
  • Ena, Javier|||0000-0002-1181-7396
  • Benito, Concha
  • Fenoll, Vicenta
  • Gil Anguita, Concepción
  • Algado Rabasa, José Tomás
  • Malmierca Corral, Eduardo|||0000-0002-4071-7247
  • González-Ruano, Patricia|||0000-0003-0395-7740
  • Rodrigo, Dolores Martín
  • Ruiz Seco, María Pilar
  • Mohamed-Balghata, Mohamed Omar
  • Gómez Vidal, María Amparo
  • De Zarraga, Miguel Alberto
  • Estrada, Vicente|||0000-0002-7795-5986
  • Téllez Molina, María Jesús
  • Vergas García, Jorge
  • Pérez-Somarriba Moreno, Juncal|||0000-0002-9623-5781
  • Górgolas, Miguel
  • Cabello-Ubeda, Alfonso|||0000-0001-8429-8358
  • Álvarez, Beatriz
  • Prieto, Laura
  • Sanz Moreno, José
  • Arranz Caso, Alberto
  • Hernández Gutiérrez, Cristina
  • Novella Mena, María
  • Galindo Puerto, María José
  • Vilalta, Ramón Fernando
  • Ferrer Ribera, Ana
  • Rivero Román, Antonio|||0000-0002-8643-4250
  • Rivero-Juarez, Antonio|||0000-0002-5813-6889
  • López López, Pedro|||0000-0001-5740-6675
  • Machuca Sánchez, Isabel|||0000-0003-3343-0085
  • Frias Casas, Mario
  • Camacho Espejo, Angela
  • Cervero Jiménez, Miguel|||0000-0001-9387-7917
  • Torres Perea, Rafael
  • Pineda, Juan A.|||0000-0002-3751-0296
  • Rincón Mayo, Pilar
  • Macías, Juan|||0000-0002-4778-790X
  • Merchante, Nicolás|||0000-0003-1120-8942
  • Real, Luis M.|||0000-0003-4932-7429
  • Corma Gómez, Anaïs|||0000-0002-1078-0237
  • Fernández Fuertes, Marta
  • Gonzalez-Serna, Alejandro|||0000-0002-0239-8417
  • Poveda, Eva|||0000-0003-4835-9875
  • Pérez González, Alexandre|||0000-0003-4836-6768
  • Crespo Casal, Manuel|||0000-0001-9016-0515
  • Morano, Luis
  • Miralles, Celia
  • Ocampo Hermida, Antonio|||0000-0002-3176-9758
  • Pousada, Guillermo|||0000-0002-2466-8094
Background: To estimate the prevalence and severity of menopausal symptoms and anxiety/depression and to assess the differences according to menopausal status among women living with HIV aged 45-60 years from the cohort of Spanish HIV/AIDS Research Network (CoRIS). Methods: Women were interviewed by phone between September 2017 and December 2018 to determine whether they had experienced menopausal symptoms and anxiety/depression. The Menopause Rating Scale was used to evaluate the prevalence and severity of symptoms related to menopause in three subscales: somatic, psychologic and urogenital; and the 4-item Patient Health Questionnaire was used for anxiety/depression. Logistic regression models were used to estimate odds ratios (ORs) of association between menopausal status, and other potential risk factors, the presence and severity of somatic, psychological and urogenital symptoms and of anxiety/depression. Results: Of 251 women included, 137 (54.6%) were post-, 70 (27.9%) peri- and 44 (17.5%) pre-menopausal, respectively. Median age of onset menopause was 48 years (IQR 45-50). The proportions of pre-, peri- and post-menopausal women who had experienced any menopausal symptoms were 45.5%, 60.0% and 66.4%, respectively. Both peri- and post-menopause were associated with a higher likelihood of having somatic symptoms (aOR 3.01; 95% CI 1.38-6.55 and 2.63; 1.44-4.81, respectively), while post-menopause increased the likelihood of having psychological (2.16; 1.13-4.14) and urogenital symptoms (2.54; 1.42-4.85). By other hand, post-menopausal women had a statistically significant five-fold increase in the likelihood of presenting severe urogenital symptoms than pre-menopausal women (4.90; 1.74-13.84). No significant differences by menopausal status were found for anxiety/depression. Joint/muscle problems, exhaustion and sleeping disorders were the most commonly reported symptoms among all women. Differences in the prevalences of vaginal dryness (p = 0.002), joint/muscle complaints (p = 0.032), and sweating/flush (p = 0.032) were found among the three groups. Conclusions: Women living with HIV experienced a wide variety of menopausal symptoms, some of them initiated before women had any menstrual irregularity. We found a higher likelihood of somatic symptoms in peri- and post-menopausal women, while a higher likelihood of psychological and urogenital symptoms was found in post-menopausal women. Most somatic symptoms were of low or moderate severity, probably due to the good clinical and immunological situation of these women.